These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37158302)

  • 41. Leveraging machine learning: Covariate-adjusted Bayesian adaptive randomization and subgroup discovery in multi-arm survival trials.
    Xiong W; Roy J; Liu H; Hu L
    Contemp Clin Trials; 2024 Jul; 142():107547. PubMed ID: 38688389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study.
    Jaki T; Wason JMS
    BMC Cardiovasc Disord; 2018 Nov; 18(1):215. PubMed ID: 30482176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adaptive multiarm multistage clinical trials.
    Ghosh P; Liu L; Mehta C
    Stat Med; 2020 Apr; 39(8):1084-1102. PubMed ID: 32048313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of phase I dose-finding designs in clinical trials with monotonicity assumption violation.
    Abbas R; Rossoni C; Jaki T; Paoletti X; Mozgunov P
    Clin Trials; 2020 Oct; 17(5):522-534. PubMed ID: 32631095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bayesian adaptive randomization designs for targeted agent development.
    Lee JJ; Xuemin Gu ; Suyu Liu
    Clin Trials; 2010 Oct; 7(5):584-96. PubMed ID: 20571130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multi-stage drop-the-losers design for multi-arm clinical trials.
    Wason J; Stallard N; Bowden J; Jennison C
    Stat Methods Med Res; 2017 Feb; 26(1):508-524. PubMed ID: 25228636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequentist operating characteristics of Bayesian optimal designs via simulation.
    Zhang Y; Trippa L; Parmigiani G
    Stat Med; 2019 Sep; 38(21):4026-4039. PubMed ID: 31215685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adding new experimental arms to randomised clinical trials: Impact on error rates.
    Choodari-Oskooei B; Bratton DJ; Gannon MR; Meade AM; Sydes MR; Parmar MK
    Clin Trials; 2020 Jun; 17(3):273-284. PubMed ID: 32063029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparing the MAMS framework with the combination method in multi-arm adaptive trials with binary outcomes.
    Abery JE; Todd S
    Stat Methods Med Res; 2019 Jun; 28(6):1716-1730. PubMed ID: 29734869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
    Ji Z; Lin J; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs.
    Wang Y; Travis J; Gajewski B
    BMC Med Res Methodol; 2022 Apr; 22(1):118. PubMed ID: 35448963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bayesian designs with frequentist and Bayesian error rate considerations.
    Wang YG; Leung DH; Li M; Tan SB
    Stat Methods Med Res; 2005 Oct; 14(5):445-56. PubMed ID: 16248347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A decision-theoretic approach to Bayesian clinical trial design and evaluation of robustness to prior-data conflict.
    Calderazzo S; Wiesenfarth M; Kopp-Schneider A
    Biostatistics; 2022 Jan; 23(1):328-344. PubMed ID: 32735010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factorial versus multi-arm multi-stage designs for clinical trials with multiple treatments.
    Jaki T; Vasileiou D
    Stat Med; 2017 Feb; 36(4):563-580. PubMed ID: 27804166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improving efficiency in the stepped-wedge trial design via Bayesian modeling with an informative prior for the time effects.
    Zhan D; Ouyang Y; Xu L; Wong H
    Clin Trials; 2021 Jun; 18(3):295-302. PubMed ID: 33813906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Designs for adding a treatment arm to an ongoing clinical trial.
    Bennett M; Mander AP
    Trials; 2020 Mar; 21(1):251. PubMed ID: 32143729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Designing multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection.
    Jaki T; Hampson LV
    Stat Med; 2016 Feb; 35(4):522-33. PubMed ID: 26456537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of phase II methodologies for single-arm clinical trials with multiple endpoints in rare cancers: An example in Ewing's sarcoma.
    Dutton P; Love SB; Billingham L; Hassan AB
    Stat Methods Med Res; 2018 May; 27(5):1451-1463. PubMed ID: 27587590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.